NovaBridge Biosciences (NBP) Profit After Tax (2019 - 2025)
NovaBridge Biosciences (NBP) reported Profit After Tax of -$72.9 million for Q4 2025, down 771.87% year-over-year from $10.8 million in Q4 2024, and down 967.05% quarter-over-quarter from -$6.8 million in Q3 2025.
NovaBridge Biosciences (NBP) Profit After Tax (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has 5 years of Profit After Tax data on file, last reported at -$72.9 million in Q4 2025.
- Profit After Tax for Q4 2025 came in at -$72.9 million, down 771.87% year-over-year; the trailing twelve-month figure through Dec 2025 was -$88.3 million (down 16198.89% YoY), and the FY2025 annual result was -$88.3 million, down 497.39% from the prior year.
- Profit After Tax eased to -$72.9 million in Q4 2025 per NBP's latest filing, from -$6.8 million in the prior quarter.
- Over five years, Profit After Tax peaked at $67.9 million in Q4 2023 and troughed at -$72.9 million in Q4 2025.
- A 3-year average of -$4.5 million and a median of -$5.5 million in 2025 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2024 and 2025: Profit After Tax jumped 141.36% in 2024, then slumped 771.87% in 2025.
- A 3-year view of Profit After Tax shows it stood at $67.9 million in 2023, then slumped by 84.03% to $10.8 million in 2024, then tumbled by 771.87% to -$72.9 million in 2025.
- Business Quant data shows NBP's Profit After Tax at -$72.9 million in Q4 2025, -$6.8 million in Q3 2025, and -$5.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -56.74 Mn |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - | -72.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -72.86 Mn |
| Sep 30, 2025 | -6.83 Mn |
| Jun 30, 2025 | -5.50 Mn |
| Mar 31, 2025 | -3.15 Mn |
| Dec 31, 2024 | 10.84 Mn |
| Sep 30, 2024 | -20.49 Mn |
| Jun 30, 2024 | 25.42 Mn |
| Mar 31, 2024 | -16.32 Mn |
| Dec 31, 2023 | 67.90 Mn |
| Sep 30, 2023 | 33.26 Mn |
| Jun 30, 2023 | -61.47 Mn |
| Dec 31, 2020 | -15.05 Mn |
| Sep 30, 2020 | 166.65 Mn |
| Dec 31, 2019 | -364.40 Mn |
| Sep 30, 2019 | 279.73 Mn |